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S_mary The kinetics of fluorescence in tumour (UT) and subcutaneous tissue (ST) and the vascular effects
of photodynamic therapy (PDT) were studied using protoporphyrin IX (PpIX). endogenously generated after
i.v. administration of 100 and 200mg kg-' 5-aminolaevulinic acid (ALA). The experimental model was a rat
skinfold observation chamber containing a thin layer of ST in which a small syngeneic mammary tumour
grows in a sheet-like fashion. Maximum TT and ST fluorescence following 200 mg kg-' ALA was twice the
value after 100mg kg-' ALA, but the initial increase with time was the same for the two doses in both TT
and ST. The fluorescence increase in ST was slower and the maximum fluorescence was less and appeared later
than in TT. Photodynamic therapy was applied using green argon laser light (514.5 nm. 100 J cm -). Three
groups received a single light treatment at different intervals after administration of 100 or 200 mg kg-' ALA.
In these groups no correlation was found between the fluorescence intensities and the vascular damage
following PDT. A fourth group was treated twice and before the second light treatment some fluorescence had
reappeared after photobleaching due to the first treatment. Only with the double light treatment was lasting
TT necrosis achieved, and for the first time with any photosensitiser in this model this was accomplished
without complete ST necrosis.
Photodynamic therapy (PDT) is an experimental cancer
treatment modality using photosensitisers that can produce
tissue destruction upon absorbing light of an appropriate
wavelength and dose. The photosensitiser Photofrin, a
derivative of haematoporphyrin, is currently under clinical
investigation. Photofrin consists of a mixture of porphyrins,
hydrophilic and hydrophobic, which have different fluor-
escent and photodynamic properties (Kessel, 1982;
Dougherty. 1987). The hydrophilic components fluoresce but
are less photodynamically active, whereas the hydrophobic
and photodynamically active components generally lack
fluorescence. Therefore, the amount of tissue fluorescence
after photosensitiser administration is not directly related to
the possible PDT effect. Besides this complexity, the major
side-effect of Photofrin administration is prolonged photosen-
sitivity of the skin (Dougherty et al., 1990). These drawbacks
have stimulated a search for better photosensitisers for
tumour localisation and PDT.
An alternative to administering exogenous photosensitiser
is to stimulate cells to generate their own photosensitiser.
This can be achieved by 5-aminolaevulinic acid (ALA), which
can be converted in situ into protoporphyrin IX (PpIX).
ALA is present in all mammalian cells and is the first com-
mitted intermediate in the haem biosynthesis pathway.
Exogenous ALA bypasses the feedback control, which is
regulated by haem, and can therefore induce an intracellular
accumulation of PpIX. PpIX is an effective photosensitiser
which is associated with the skin phototoxicity seen in
patients with porphyria (Jarrett et al., 1956; Shanley et al.,
1972). Animal experiments have shown that after intravenous
(i.v.) ALA administration only certain types of tissues
manifest PpIX fluorescence (Bedwell et al., 1992; Loh et al.,
1992). This tissue-specific photosensitisation provides a basis
for using ALA-induced PpIX for tumour localisation and
photodynamic therapy. In contrast to Photofrin, the
fluorescence intensity after ALA administration is an indica-
tion of the PpIX concentration in tissues (Loh et al., 1993a).
Therefore, fluorescence kinetics can probably be used for
determining the optimum interval between ALA administra-
tion and light treatment. Another advantage of ALA-induced
PpIX is the various possibilities for administration of ALA,
besides i.v. Promising results have been obtained in treating
basal cell carcinomas using topically applied ALA (Kennedy
& Pottier, 1992). With topical application an enhanced selec-
tive effect with PDT can be expected because of the restric-
tion of the induced sensitiser to the lesion and the
immediately surrounding normal skin. Loh et al. (1993b)
reported selective fluorescence of inoperable rectal adenocar-
cinomas after oral administration in two patients. Grant et
al. (1993) treated patients suffering from oral cavity
squamous cell carcinomas with PDT after oral ALA adminis-
tration. They found no side-effects and a rapid clearance of
the sensitiser within 24 h.
In this paper we describe the fluorescence kinetics of PpIX
in rat mammary tumour and subcutaneous tissue after two
i.v. doses of ALA. Based on the fluorescence dynamics,
different treatment time points post injection (p.i.) were
chosen and a comparison was made between the photo-
dynamic effects with the two drug doses and different inter-
vals between ALA administration and light treatment.
Finally, the vascular effects during and after treatment and
the role of these effects on the outcome of tumour tissue
necrosis are discussed.
Material and methods
Chemical
ALA was obtained as hydrochloride in 98% pure powder
form from Sigma Chemie (Bornem, Belgium). It was dis-
solved in phosphate-buffered saline and immediately admini-
stered i.v. via a tail vein.
Animal model
All studies were performed on 12-week-old female WAG/Rij
rats weighing 110-120 g and supplied by ITRI/TNO, Rijs-
wijk, The Netherlands. The model used was a skinfold obser-
vation chamber previously described by Reinhold et al.
(1979). The transparent chamber (I cm diameter of visible
tissue) contains a thin layer of subcutaneous tissue (approx-
imately 0.6 mm thick), with paired small arterioles (approx-
imately 0.03 mm) and venules (approximately 0.1 mm), in
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which a transplantable tumour can grow in a sheet-like
fashion. Briefly, the chamber was attached to a pi-e of mica
(4.5 x 2.5 cm) which was subcutaneously implanted in the
skinfold A piece of plastic was placed over the skinfold to
protect the chamber. After 2 weeks' preparation time a small
piece of syngeneic mammary carcinoma (0.5 mm3) was trans-
planted into the tissue close to a large blood vessel. During
all surgical procedures Hypnorm (fluanisol/fentanyl muxture,
Janssen Pharmaceutcs, Belgium) was used as an anaethetic
and garamycin (Essex Laboratories) was administered to pre-
vent bacterial infection. To ensure adequate tumour growth
the animal was kept in a temperature-controlled cabinet at
32-C. The ambient light level was less than 30#W cm-2, with
a 12/12 h light/dark interval, to prevent unwanted photo-
dynamic damage after sensitisation of the animal. Approx-
imately I week after transplantation, when the tumour had
grown to about 3 mm diameter and adequate circulation in
both tumour and subcutaneous tissu had establshed,
experiments were started.
Fluorescence kinetics studies
T'he fluoresnce set up conisted of a charge-coupled device
(CCD) camera with a two-stage image intensifier and a
25 mm Leitz Photar macrolens. Fluorescence was excited
with 514.5 nm argon laser light usng 0.1 mW cm-2 and
fluorescnce was detect through a high-pass coloured glass
filter (OG 570). For each recording the chamber was exposed
to the excitation light for a period of 60 s. About ten record-
ings were made, so that the maximal light dose was
0.06Jcm-2, which proved to be suffKicly low to avoid
photodynamic damage. Animals were anaesthetised with
Hypnorm and placed on a temperature-controled stage
under the CCD camera. An autofluorescence image was
recorded before i.v. ALA administration. Two groups, each
of six animals, received 100 or 200mgkg-' ALA, and at
various time intervals from 30 up to 360min p.i. fluorescence
images were recorded and stored in the computer. Fluor-
escence was quantified digitally by alculating the mean
gryscale value within selected areas of the recorded
fluorescence image. All fluorescence measurements, except
those recorded after a light treatment (Figure 3), were cor-
rected for their autofluorescne signals in the same area
before ALA adminitation.
Phototherap) studies
Four groups, each of six animals receiving 100 or
200 mg kg-' ALA, were treated at different starting points
p.i. The treatment starting points were based on the results
obtained from the fluorescence experiments (Table I).
Animals were anaesthetised and placed on a temperature-
controlled stage of a microscope. The circulation of arterioles
and venules of subcutaneous tissue (ST) and the capillary
beds of ST and tumour tissue (TT) was observed at a
magnification from lOx up to 120x. Through an optical
fibre and a lens system with diaphragm a uniform beam of
514.5 nm light, with a power density of 100 mW cm-2, was
projected through the stage onto the back of the entire
chamber. Green light was chosen for conveniene, since this
was also used for fluorescence excitation and is at least as
effective for PDT as red light. The tissue layer of the
chamber is so thin that green light penetration is suffiient,
and we saw no difference in damage between both sides of
the chamber. The treatment dose was 100 J cm-2, which
required a treatment time of 17 min. After 5 min (30J cm-)
the irradiation was briefly interrupted to determine whether
immedi;ate constriction of the vessels occurred. It should be
noted that TT only contains small capillaries and no large
venules and arterioles like ST. Up to 7 days after treatment
the status of the circulation was determined daily. The total
damage to iT And ST was translated into a score on a 0-8
scale, i.e. nine levels. Damage scores during and at the end of
the treatment were based on effects other than those
observed at 1-7 days after treatment. During treatment
effects such as ischaemia, constriction and stasis were
observed. From I to 7 days after treatment vascular stasis
was the predominant observation and was therefore also the
dominant factor in the damage score (Tabk II). If the cir-
culation ofTT had not completely recovered after 7 days, the
content ofthe chamber was transplanted into the flank ofthe
same animal to see whether regrowth would indicate the
presence of viable tumour cells.
Resdt
Fluorescence kinetics studies
The fluorescence data of TT and ST after i.v. administration
of l00mglkg-' ALA are shown in Figure la and those of
Table I Snumary of the phototherapy studis on four groups of
animal reiving lOOor2O mgkg-' ALAandtreatedatdifferenttimes
p.i.
ALA dose Light ae PDTp.i. Fhescence
Group (mgkg-') (Jcmn2) (min) at PDT
A 100 100 120 max. diff. TT-ST
B 200 100 150 max. diff. TT-ST
C 200 100 60 1/3 ofmax. diff. 1TY-ST
D 200 100/100 60/150 1/3 and max. diff. TT-ST
max, maximal; diff, diff c; TT, tumour tssue ST, subcutaneous
tusse.
TablkI Circulationdamag scoresusedforquantificationofvasculardamag byPDTtotumourtissuesandsubcutaneoustissue in
the skinfold observation chamber. Intermediate scores were assigned to dama levels between those defined in the table
Circulation Subutawous tir Tumour tise
damae During and 1-7days During and 1-7 days
score after PDT after PDT after PDT after PDT
0 No observable damage to capillaris or venules
2 Arteriolar spasm t:25% capillary stass Ischaia -25% capillary stass
4 ;50% capllary stasis -50% capillary stasis Dilatation and -50% capillary stass
Mildly reduced RBCC in Mikily reduced blood ;50% capillary stasis
venules and arteriolar spasm flow in vessels
6 t75% capillary stasis 75% capillary stasis Dilatation and -75% capillary stasis
Strongly reduced RBCC in Strongly reduced blood :75% capillary stass
venules and artiolar spasm fow in vessels
8 No observable circulation tocapillaries or venules
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Fugwe 1 Fluorescence kinetcs, ± standard error of the mean
(s.e.m.), expressed as greyscale vahls, of tumour tissue and
subcutaneous tissue after administration of 100 a, and 200mg
kg- I b, ALA. Both doses wre studied in six animals each.
Fluorescence measurements were corrected for their auto-
fluowrescence. *, TI; *, ST.
200mg kg-' ALA in Figure lb. All values in these graphs
were corrected for background fluoresnce using the
autofluorescence image, which had a greyscale level of 25 for
both TI and ST. With both drug doses, at all intervals
recorded, no fluorescence of the blood vessels could be
detected. For TI an almost similar increase in fluorescence
was observed during the first 90 min p.i. for both drug doses.
After 90min p.i. the fluorescence intensity in the 100 mg
kg-' group levellEd off, reaching a peak at 150min p.i., after
which fluorescence intensity declined rapidly. With
200 mg kg-' ALA an increase could be observed until
240 min p.i. and maximal fluorescence intensity was almost
twice the value of that with 100 mg kg-' ALA. Fluorescence
of ST after both doses increased more slowly than that of
TI. With both doses, nearly the same increase of
fluorescence was observed during the first 150 min. After
150 min p.i. fluorescence maintained the same level during at
least 120min with 100mgkg-'. With 200mglkg-' an in-
crease could be observed up till 330 min p.i. and the maximal
intensity was twice that with 100mgkg-'. With both doses
the fluorescence intensity of TI and ST had retuned to
background level at 24h p.i.
Phototherapy studies
Vascular effects of ALA-PDT were examined in four groups
of six rats each, differing in ALA drug dose and/or treatment
starting point p.i. (Table I). Treatment starting points p.i. of
groups A (120 min p.i.) and B (150 min p.i.) were taken at
the maximum difference between TT and ST fluorescence.
Observed vascular damage effects during and after treatment,
expressed as damage scores using Table H, are shown in
Figure 2a for group A and Figure 2b for group B. Despite
differences in fluorescence intensity between group A and B
at the treatment starting point, hardly any differences in
circulation damage during and after treatment were observed.
After 5 min of light treatment strong constriction of venules,
disappearing artenroles in ST and ischaemia in TT were
observed. After treatment, constriction was maximal and in
TI some vasodilatation was observed. Maximum circulation
damage of both TI and ST was reached I day after treat-
ment for group A and 2 h (data not shown in Figure 2) after
treatment for group B, but there was no complete circulation
stop. One day after treatment circulation started to recover,
and 6 days later hardly any damage remained visible. In both
groups studied no distinct selective circulation damage of TT
during and after treatment was observed.
Group C was treated at 60 min p.i. using 200 mgkg-'
ALA. The vascular damage effects during and after light
treatment are shown in Figure 2c. There was hardly any
constriction of venules during treatment. The arterioles con-
stricted but emained visible and there was a mild ischaemia
in TI. Maximum damage was reached 1 day after treatment,
after which the circulation started to recover. There was a
selective TI damage but no complete circulation stop was
observed.
Group D (200mgkg-') received two light treatments, at
60 and 150min p.i. Before and after the treatments
fluorescence images were recorded to examine if photo-
bleaching had ocurred during the irradiation and if new
fluorescence was formed after the first light treatment. This
would indicate the presence of new porphyrin that could be
used to increase the effectiveness ofPDT. The results ofthese
fluorescence recordings are shown in Figure 3. The values in
this graph were not corrected for background fluorescence.
After the first light treatment photobleaching of fluorescence
occurred to a level slightly below the autofluorescence inten-
sity. Just before the second light treatment new fluorescence
was observed and after treatment it had returned to the mme
level as after the first treatment. The vascular damage scores
of the two subsequent light treatments are shown in Figure
2d. During the first treatment the same constrction of
arterioles (Figure 4b) occurred as in group C. Before the
second treatment constriction in ST and the circulation in TI
had recovered to some extent. During the second treatment
the same vascular constriction of venules and arterioles was
seen as in groups A and B (Figure 4c). At the end of the
second treatment complete stasis ofthe circulation in TI was
observed. The damage to ST on day I was maximal (but not
complete) and recovered to some extent, but even after 7
days some areas remained damaged. Necrosis of TI persisted
for 7 days, with the exception of one tumour which showed
some cirulation at its border 4 days post treatment. In this
group the contents of the chamber were retransplantated
after 7 days and only two out of six tumours showed
regrowth.
Fluorescence kinetic studies
In this study we have examined the fluorescence kinetics of
TI and ST after 100 and 200 mg kg-' i.v. adminisered
ALA. After both ALA doses the rate offluorescence increase
in TI was higher than in ST. It is known that various
malignant tissues have a higher activity of porphobilinogen
deaminase (PBGD) and a decreased activity of ferrochelatase
(van Hillegersberg et al., 1992). Therefore, it is likely that the
higher rate of fluorescence increase in TI may represent a
higher capacity for conversion of ALA to porphyrin or PpIX
to haem or a combination of both.
Another explanation for a higher rate of increase in TI
may be a higher ALA uptake. However, if ALA uptake
determined the rate of fluorescence increase, a steeper rate of
increase would be expected after a higher ALA dose. This
did not occur, and although maximal fluorescence intensity
was twice that after 200mgkg-' administered ALA, the
same maximal rate of increase of fluorescence in both tissues
was observed as after 100mg kg-'. As a result, the time to870 N. VAN DER VEEN et al.
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Fuge 2 Circulation damage scores (± s.e.m.) of tumour tissue ( X, TT) and subcutaneous tissue ( i, ST), during (min after
start of irradiation) and after light treatment (days). Animals received 100 or 200 mg kg-' ALA and were treated with a light dose
of 100 Jcm2 (lOOmWcm-2, 514.5 nm), at different time points p.i. a, lOOmglkg-', n=6, 120min p.i.; b, 200mglkg-', n=6,
150 min p.i.; c, 200 mg kg-', n = 6, 60 min p.i.; d, 200mg kg-', n = 6, 60 (O = before PDT at 60 min p.i.) and 150 min (0* = before
PDT at 150 min p.i.) p.i.
reach maximal fluorescence was longer for the higher ALA
dose. This was also found in the normal skin of mice by
Pottier et al. (1986). It may indicate that the limiting factor
in the rate of fluorescence increase is the biosynthesis of
haem.
An interesting observation is the difference between T[
and ST in the time required to reach maximal fluorescence.
Maximal TT fluorescence was reached earlier than maximal
ST fluorescence and as a result ST fluorescence was still
increasing at a point when TT fluorescence had already
decreased. This is not compatible with ALA uptake in TT
higher than in ST and with a reduction in ferrochelatase
activity in TT. It is likely that i.v. administered ALA is
rapidly cleared from the circulation. This results in a strong
reduction of available ALA for TT in the course of time. It
may be possible that maximal ALA accumulation in cells
takes place directly after injection and that ALA, or an
intermediate of the haem synthesis, is retained there. As a
result, ALA or intermediates in the cell will be depleted faster
in 1T owing to the increased PpIX synthesis. This could
explain why TT fluorescence started to decrease before ST
fluorescence. The difference in maximum fluorescence
between 1T and ST may then be explained by a difference in
ALA uptake.
We observed no difference in fluorescence kinetics follow-
ing i.p. or i.v. administered ALA (unpublished data). Loh et
al. (1993b) found that the fluorescence kinetics after oral
ALA administration was similar to that after i.v. admin-
istered ALA, although a higher ALA dose was necessary to
achieve the same tissue concentrations of PpIX. Therefore,
no difference in fluorescence kinetics after oral ALA adminis-
tration compared with i.v. is expected to occur in our model.
Whether fluorescence kinetics after topical ALA is similar to
i.v. ALA will be investigated in this model in future.
Phototherapy studies
The vascular effects during and after treatment were
examined in four groups of animals differing in ALA dose
and interval between ALA administration and light treat-
ment. Treatment time points were chosen based on the
observed fluorescence kinetics after 100 and 200mg kg-'
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ALA. The chambers of the first two groups (A and B) were
treated at maximal difference between TT and ST. These
experiments were set up to achieve maximal selective TT
circulation damage. Therefore, the chambers were treated at
maximal difference between TT and ST fluorescence and not
at maximal fluorescence.
Despite differences in fluorescence intensities between the
two doses of ALA and between TT and ST, no differences in
the level of circulation damage could be observed. Further-
more, the overall circulation damage effects were relatively
minor, and there was no complete circulation stop in TT.
The basis of the apparent discrepancy between the fluor-
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Figure 3 Photobleaching of fluorescence (± s.e.m.) in tumour
( , TT) and subcutaneous tissue ( ST), recorded in six
animals treated with 100jcm2 514.5 nm light at 60 as well as
150 min p.i. Note that, after treatment at 77 and 207 min p.i.,
fluorescence is somewhat less than the autofluorescence before
ALA administration. A horizontal dashed line has been drawn at
the level of initial autofluorescence to emphasise the differences in
fluorescence before and after the light treatments. The
autofluorescence has not been subtracted from the fluorescence
measurements after ALA administration.
escence intensities and the lack of photodynamic damage
may be the strong vascular constriction during treatment
observed after both ALA doses. These vascular effects during
treatment are similar to those observed with almost all sen-
sitisers investigated in this model (Star et al., 1986; van
Leengoed et al., 1993). An optimal oxygen supply during
treatment is necessary to obtain tissue damage with PDT
(Moan & Sommer, 1985; Henderson & Fingar, 1987).
Therefore, a reduction in tissue oxygenation as a result of
vascular shutdown during treatment limits the effectiveness of
PDT.
No constriction was observed during treatment at 60 min
p.i. with group C (200mgkg-'). This lack of constriction
during treatment could be caused by a low capacity of
endothelial cells to generate PpIX. Although the fluorescence
intensity was less, a larger and a more selective level of TT
damage was obtained compared with a treatment at maximal
difference in fluorescence between TT and ST. This may have
been made possible by the blood supply remaining intact
during treatment. The increased selective effects on TT
treated at 60 min p.i. could also be the result of translocation
within the cell of porphyrin from the mitochondrion to less
sensitive sites (Kessel, 1986; Malik & Lugaci, 1987). Since
PpIX is formed in the mitochondrion and because the
mitochondrion is very sensitive for PDT damage (Hilf, 1986;
Salet, 1986) an increased effect may be expected when
treating at an interval where the rate of fluorescence increase
is maximal as done in group C.
In summary, in this model no correlation was found
between the fluorescence intensity and the level of damage
after a single light treatment. As discussed, two factors may
determine the level of damage after treatment: the quality of
blood supply during treatment and the localisation of PpIX
in the cell in the course of time. Based on the results
obtained with our experiments the optimal interval for a
single light treatment may be early p.i. when the maximal
rate of PpIX accumulation is observed and no vascular con-
striction during treatment seems to occur.
The relative importance of the intracellular localisation of
PpIX and the vascular effects during treatment may be deter-
Figure 4 Status of the vasculature before a, and during the first light treatment at 60 min b, and the second light treatment at
150 min p.i. c. During the early treatment b, constriction of the arteriole (arrow) occurred, but it remained visible. This arteriole
disappeared during the second treatment and a strong constriction of the larger venule was seen. The border of the tumour on the
photograph looks dark because of fat cells and there was minor necrosis in the centre of the tumour.
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mined by in vitro experiments. With in vitro studies condi-
tions of oxygen supply can be kept constant and the localisa-
tion of PpIX in the cell in relation to damage after treatment
can be examined. On the other hand, we plan to study the
effect of vasoconstriction during treatment on the outcome of
TT damage in the observation chamber model by modulating
the vascular response with a cyclo-oxygenase inhibitor.
With two subsequent light treatments, at 60 and 150 min
p.i.. complete necrosis in TT during the observation period
could be achieved while permanently damaging only a
relatively small area of ST. With all dyes studied in this
model so far (Star et al.. 1986; van Leengoed, 1993), a large
area of permanent ST necrosis was necessary to yield perma-
nent TT necrosis. This could indicate an increased fraction of
direct tumour cell kill by ALA-PDT, compared for example
with PDT using Photofrin, where this fraction is quite small
(Henderson & Fingar, 1987).
During the recovery period of 75 mmn between the end of
the first and the beginning of the second treatment the minor
constriction caused by the first treatment recovered. After the
first light treatment the fluorescence had bleached to a level
slightly below the autoflourescence. This could be caused by
bleaching of naturally occurring fluorochromes, for example
degradation products of chlorophyll present in animal food
(Weagle et al., 1988). However, no photodynamic damage
was observed in control animals treated with light alone.
Before the second treatment new fluorescence in TI and
ST was observed which was less, in absolute terms, than
observed in untreated animals at similar time points. This
might indicate that after the first treatment cells were
damaged and had therefore lost haem-generating capacity.
Cells that still have that capacity can form new PpIX. Dan et
al. (1993) reported about a decreased ferrochelatase activity
in cells after a single light treatment. This induced decrease
can result in an increase in the rate of PpIX accumulation.
These cells may be damaged severely by the second treat-
ment, which might explain the increased damage effects after
two subsequent treatments. Another possible explanation for
the severe damage effects with two subsequent treatments
may be that cells that are damaged by the first treatment will
release PpIX. This PpIX may then cause damage to other
cells during the second treatment. However this is not likely
to occur because complete bleaching after the first treatment
was observed.
In conclusion, no direct correlation was found between
fluorescence intensity and the amount of vascular damage to
TT and ST in this model after i.v. administration of ALA.
With a single light treatment no complete circulation stop in
TT was obtained. Only with a double treatment could persis-
tent tumour necrosis be obtained without causing complete
necrosis of the surrounding subcutaneous tissue.
Abbreviadom
PDT, photodynamic therapy; TT. tumour tissue: ST. subcutaneous
tissue; p.i. post injection; ALA, 5-aminolaevulinic acid; PpIX, Pro-
toporphyrin IX; s.e.m.. standard error of mean.
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